CUA Educational Content

Evolving Treatment Paradigms in Advanced Urothelial Carcinoma

Featuring: Shilpa Gupta (Taussig Cancer Institute, Cleveland Clinic Foundation)

By participating in this program, participants can expect to:

  • review of latest evidence for treatment of advanced urothelial cancer
  • discuss the perspective on multidisciplinary approaches to optimize first line SOC treatments of chemotherapy and immunotherapy
  • gain insight on new approaches/research to further advance standard first-line treatment options for advanced urothelial carcinoma



This program has received financial support from EMD Serono and Pfizer in the form of an educational grant.